Richard Shames

1.3k total citations
20 papers, 911 citations indexed

About

Richard Shames is a scholar working on Physiology, Immunology and Surgery. According to data from OpenAlex, Richard Shames has authored 20 papers receiving a total of 911 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 6 papers in Immunology and 3 papers in Surgery. Recurrent topics in Richard Shames's work include Asthma and respiratory diseases (7 papers), Eosinophilic Esophagitis (3 papers) and IL-33, ST2, and ILC Pathways (3 papers). Richard Shames is often cited by papers focused on Asthma and respiratory diseases (7 papers), Eosinophilic Esophagitis (3 papers) and IL-33, ST2, and ILC Pathways (3 papers). Richard Shames collaborates with scholars based in United States, Canada and Germany. Richard Shames's co-authors include Vladimir Vexler, Thomas N. Robinson, Paul J. Sharek, Dale T. Umetsu, David A. Bergman, Hidemi Nakagawa, Diamant Thaçi, Kristian Reich, Q. Li and Yijie Zhou and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Richard Shames

17 papers receiving 883 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard Shames United States 12 365 348 176 175 124 20 911
Eero Pukkala Finland 16 210 0.6× 140 0.4× 272 1.5× 184 1.1× 70 0.6× 17 1.3k
Kinga Sałapa Poland 16 92 0.3× 223 0.6× 57 0.3× 129 0.7× 45 0.4× 59 589
Marisol E. Otero Netherlands 18 426 1.2× 83 0.2× 277 1.6× 29 0.2× 162 1.3× 25 821
Blanca Rueda‐Medina Spain 21 376 1.0× 173 0.5× 19 0.1× 139 0.8× 157 1.3× 78 1.2k
Michiko Kurosawa Japan 27 272 0.7× 162 0.5× 117 0.7× 307 1.8× 72 0.6× 53 1.8k
Kaspar René Nielsen Denmark 19 129 0.4× 131 0.4× 82 0.5× 77 0.4× 74 0.6× 75 1.4k
Kunal K. Gandhi United States 20 496 1.4× 474 1.4× 64 0.4× 102 0.6× 58 0.5× 61 1.8k
C. Julian Rosenthal United States 20 147 0.4× 131 0.4× 84 0.5× 265 1.5× 61 0.5× 46 1.5k
William Helsel United States 17 62 0.2× 117 0.3× 52 0.3× 90 0.5× 66 0.5× 26 1.1k
Brian Calimlim United States 19 136 0.4× 318 0.9× 813 4.6× 109 0.6× 31 0.3× 70 1.4k

Countries citing papers authored by Richard Shames

Since Specialization
Citations

This map shows the geographic impact of Richard Shames's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Shames with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Shames more than expected).

Fields of papers citing papers by Richard Shames

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Shames. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Shames. The network helps show where Richard Shames may publish in the future.

Co-authorship network of co-authors of Richard Shames

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Shames. A scholar is included among the top collaborators of Richard Shames based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Shames. Richard Shames is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Modi, Nishit B., Richard Shames, Jason D. Lickliter, & Suneel Gupta. (2024). Pharmacokinetics, pharmacodynamics, and tolerability of an aqueous formulation of rusfertide (PTG‐300), a hepcidin mimetic, in healthy volunteers: A double‐blind first‐in‐human study. European Journal Of Haematology. 113(3). 340–350. 3 indexed citations
2.
Sandborn, William J., Larry Mattheakis, Nishit B. Modi, et al.. (2021). PTG-100, an Oral α4β7 Antagonist Peptide: Preclinical Development and Phase 1 and 2a Studies in Ulcerative Colitis. Gastroenterology. 161(6). 1853–1864.e10. 28 indexed citations
3.
Papp, Kim, Diamant Thaçi, Kristian Reich, et al.. (2015). Tildrakizumab (MK-3222), an anti-interleukin-23p19 monoclonal antibody, improves psoriasis in a phase IIb randomized placebo-controlled trial. British Journal of Dermatology. 173(4). 930–939. 228 indexed citations
4.
Shames, Richard. (2012). Diagnostic Challenges and Treatment Options for Thyroid Conditions. Alternative and Complementary Therapies. 18(1). 8–13.
5.
Israel, Elliot, Harold S. Nelson, James Baker, et al.. (2008). Daclizumab Improves Asthma Control in Patients with Moderate to Severe Persistent Asthma. American Journal of Respiratory and Critical Care Medicine. 178(10). 1002–1008. 110 indexed citations
6.
7.
Nelson, Harold S., William W. Busse, Elliot Israel, et al.. (2005). Daclizumab improves asthma control in patients with refractory asthma. Journal of Allergy and Clinical Immunology. 115(2). S134–S134. 10 indexed citations
8.
Shames, Richard, Paul J. Sharek, Michelle L. Mayer, et al.. (2004). Effectiveness of a multicomponent self-management program in at-risk, school-aged children with asthma. Annals of Allergy Asthma & Immunology. 92(6). 611–618. 66 indexed citations
9.
Baker, James, et al.. (2004). Preliminary safety and efficacy of daclizumab in the treatment of patients with moderate to severe chronic persistent asthma. Journal of Allergy and Clinical Immunology. 113(2). S286–S287. 9 indexed citations
10.
Shames, Richard. (2002). Gender differences in the development and function of the immune system. Journal of Adolescent Health. 30(4). 59–70. 74 indexed citations
11.
Sharek, Paul J., Michelle L. Mayer, Thomas N. Robinson, et al.. (2002). Agreement Among Measures of Asthma Status: A Prospective Study of Low-Income Children With Moderate to Severe Asthma. PEDIATRICS. 110(4). 797–804. 71 indexed citations
12.
Dahl, Gary V., et al.. (2001). Weekly Dosing of Carboplatin Increases Risk of Allergy in Children. ˜The œAmerican journal of pediatric hematology/oncology. 23(6). 349–352. 51 indexed citations
13.
Shames, Richard, et al.. (2001). Thyroid Power: Ten Steps to Total Health. 1 indexed citations
14.
Shames, Richard, Morton J. Cowan, & Dale T. Umetsu. (1999). Pulmonary Atypical Mycobacterial Infection in a Child with Severe Combined Immune Deficiency. Pediatric Asthma Allergy & Immunology. 13(2). 79–85.
15.
Kishiyama, Jeffrey L., David J. Valacer, Charlotte Cunningham‐Rundles, et al.. (1999). A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of High-Dose Intravenous Immunoglobulin for Oral Corticosteroid-Dependent Asthma. Clinical Immunology. 91(2). 126–133. 51 indexed citations
16.
Shames, Richard, et al.. (1998). Clinical Differences Among Women with and Without Self-Reported Perimenstrual Asthma. Annals of Allergy Asthma & Immunology. 81(1). 65–72. 62 indexed citations
17.
Shames, Richard, et al.. (1994). Tumor necrosis factor release by murine macrophages stimulated by the cytotoxic ether lipid 1-O-hexadecyl-2-O-methyl-SN-glycero-3-phosphorylcholine (ET-18-O-OCH3). International Journal of Immunopharmacology. 16(4). 335–343. 5 indexed citations
18.
Goetzl, Edward J., Richard Shames, H. J. Yang, et al.. (1994). Inhibition of human HL-60 cell responses to chemotactic factors by antisense messenger RNA depletion of G proteins.. Journal of Biological Chemistry. 269(2). 809–812. 24 indexed citations
19.
Shames, Richard & Edward J. Goetzl. (1993). Activation of human neutrophil LFA-1 (CD11a) by leukotriene B4. Inflammation. 17(3). 371–382. 4 indexed citations
20.
Robichon, Alain, Sunil P. Sreedharan, Jun Yang, et al.. (1993). Induction of aggregation of Raji human B-lymphoblastic cells by vasoactive intestinal peptide.. PubMed. 79(4). 574–9. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eero Pukkala Breakdown of academic impact, for papers by Kinga Sałapa Breakdown of academic impact, for papers by Marisol E. Otero Breakdown of academic impact, for papers by Blanca Rueda‐Medina Breakdown of academic impact, for papers by Michiko Kurosawa Breakdown of academic impact, for papers by Kaspar René Nielsen Breakdown of academic impact, for papers by Kunal K. Gandhi Breakdown of academic impact, for papers by C. Julian Rosenthal Breakdown of academic impact, for papers by William Helsel Breakdown of academic impact, for papers by Brian Calimlim
Rankless by CCL
2026